World News

What to Expect During a Skin Cancer Screening

Ogkologos - 31 Μαΐου, 2022

Lorlatinib in First-Line Treatment of Patients with Advanced ALK-Positive NSCLC With...

Ogkologos - 30 Μαΐου, 2022

What Are Clinical Practice Guidelines and How Do They Impact Care...

Ogkologos - 27 Μαΐου, 2022

Cancer in Lymph Nodes May Help Tumors Spread by Enlisting Immune...

Ogkologos - 27 Μαΐου, 2022

EMA Recommends Extension of Therapeutic Indications for Axicabtagene Ciloleucel

Ogkologos - 27 Μαΐου, 2022

Reunión anual de la ASCO de 2022: Gasto en servicios sociales...

Ogkologos - 26 Μαΐου, 2022

2022 ASCO Annual Meeting: Social Services Spending and Cancer Survival, Clinical...

Ogkologos - 26 Μαΐου, 2022

Five Questions With…Fern, Christina, Mary, and Shelley.

Ogkologos - 26 Μαΐου, 2022

NHS ‘understaffed and underequipped’ to tackle cancer, say 3 in 4...

Ogkologos - 25 Μαΐου, 2022

Copanlisib Could Be a Viable Therapeutic Option for Select PIK3CA-Mutated Cancers

Ogkologos - 25 Μαΐου, 2022

1...195196197...432 Σελίδα 196 από 432

MOST POPULAR

Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data From...

15 Ιουνίου, 2022

Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small...

25 Οκτωβρίου, 2026

ESMO Call for Stronger Cancer Prevention and Care Mirrored in WHO...

4 Ιουλίου, 2025

Two Drugs Work Together to Block ‘Master Regulator’ of Breast, Other...

4 Σεπτεμβρίου, 2018

Φόρτωση περισσοτέρων

What to Expect During a Skin Cancer Screening

Lorlatinib in First-Line Treatment of Patients with Advanced ALK-Positive NSCLC With...

What Are Clinical Practice Guidelines and How Do They Impact Care...

Cancer in Lymph Nodes May Help Tumors Spread by Enlisting Immune...

EMA Recommends Extension of Therapeutic Indications for Axicabtagene Ciloleucel

Reunión anual de la ASCO de 2022: Gasto en servicios sociales...

2022 ASCO Annual Meeting: Social Services Spending and Cancer Survival, Clinical...

Five Questions With…Fern, Christina, Mary, and Shelley.

NHS ‘understaffed and underequipped’ to tackle cancer, say 3 in 4...

Copanlisib Could Be a Viable Therapeutic Option for Select PIK3CA-Mutated Cancers

MOST POPULAR

Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data From...

Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small...

ESMO Call for Stronger Cancer Prevention and Care Mirrored in WHO...

Two Drugs Work Together to Block ‘Master Regulator’ of Breast, Other...

HOT NEWS

Adagrasib Shows Promising Activity as Monotherapy, Even Greater in Combination with...

First targeted treatment approved for advanced prostate cancer on NHS in...

When Ellen Found Out There Was A Grieving Mother In The...

Expressive Writing, What is It?

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ